20665 1 ap anti synapsin i primary (Proteintech)
Structured Review
20665 1 Ap Anti Synapsin I Primary, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 452 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synapsin+i/PSD95-Specific%2CDLG4+Antibody/pm41933661-135-9-8
Average 96 stars, based on 452 article reviews
Images
Related Articles
Incubation:Article Title: Young plasma reverses anesthesia and surgery-induced cognitive impairment in aged rats by modulating hippocampal synaptic plasticity. Article Snippet: The samples were blocked in PBS containing 0.3% Triton X-100 (Sigma-Aldrich, Munich, Germany) and 5% bovine serum album (Beyotime, Beijing, China) for 2 h at room temperature. .. The samples were then incubated with synapsin-I (Proteintech, 1:100, Cat No. 17785-1- AP), p-CREB (Cell Signaling Technology, 1:100, Cat. no. 9198S), and Ubiquitin Proteomics:Article Title: The yeast prion protein Sup35 initiates α-synuclein pathology in mouse models of Parkinson's disease. Article Snippet: .. The following primary antibodies were used in this study: GFP (Proteintech, 66002-1-Ig), Sup35 (Abnoca, PAB15578), glyceraldehyde phosphate dehydrogenase (Proteintech, 60004-1-Ig), phospho–α-Syn (Ser129) (Biolegend, MMS-5091), phospho–α-Syn (Ser129) (Cell Signaling Technology, 23706), synaptophysin (Proteintech, 17785-1-AP), PSD-95 (20665-1-AP), synapsin I (Proteintech, 20258-1-AP), α-syn (syn211, Invitrogen, MA5-12272), glutathione S-transferase (66001-2-Ig), NeuN (Millipore, MAB377), TH (Millipore, AB152), DAT (Abcam, ab184451), ubiquitin (Cell Signaling Technology, 3936S), p62 (Abcam, 56416), Microtuble-associated Article Title: Islet amyloid polypeptide triggers α-synuclein pathology in Parkinson's disease. Article Snippet: Pathologic aggregation and prion-like propagation of α-synuclein (α-syn) are the hallmarks of Parkinson’s disease (PD).. Emerging evidence shows that type 2 diabetes mellitus (T2DM) is a risk factor for PD.. Interestingly, T2DM is characterized by the amyloid deposition of islet amyloid polypeptide (IAPP) in the pancreas. Article Title: CHIP Decline Is Associated With Isoflurane-Induced Neurodegeneration in Aged Mice Article Snippet: .. Rabbit antibodies were Article Title: The yeast prion protein Sup35 initiates α-synuclein pathology in mouse models of Parkinson’s disease Article Snippet: .. The following primary antibodies were used in this study: GFP (Proteintech, 66002-1-Ig), Sup35 (Abnoca, PAB15578), glyceraldehyde phosphate dehydrogenase (Proteintech, 60004-1-Ig), phospho–α-Syn (Ser 129 ) (Biolegend, MMS-5091), phospho–α-Syn (Ser 129 ) (Cell Signaling Technology, 23706), synaptophysin (Proteintech, 17785-1-AP), PSD-95 (20665-1-AP), synapsin I (Proteintech, 20258-1-AP), α-syn (syn211, Invitrogen, MA5-12272), glutathione S -transferase (66001-2-Ig), NeuN (Millipore, MAB377), TH (Millipore, AB152), DAT (Abcam, ab184451), ubiquitin (Cell Signaling Technology, 3936S), p62 (Abcam, 56416), Microtuble-associated Lysis:Article Title: Cystatin C promotes cognitive dysfunction in rats with cerebral microbleeds by inhibiting the ERK/synapsin Ia/Ib pathway. Article Snippet: .. Materials and reagents used in this study were purchased from commercial sources: Human cystatin C kit (item no. ab179883) from Abcam; CysC drug from Enzo Life Sciences; RIPA lysis buffer from Beyotime Biotechnology Co., Ltd.; sucrose, glucose, KCl, NaHCO3, NaH2PO4, CaCl2 and MgCl2 from Sigma‐Aldrich; Merck KGaA; rat brain stereotaxic device from Anhui Zhenghua Biological Instrument Co., Ltd.; primary antibodies to cystatin C (item no. ab109508), p-extracellular signal-regulated kinase 1/2 (ERK1/2) (item no. ab223500), synapsin I (item no. ab8), and p‐synapsinI‐S549 (item no. ab119370) from Abcam; and Labeling:Article Title: Cofilin 1 promotes the aggregation and cell-to-cell transmission of α-synuclein in Parkinson's disease. Article Snippet: The histopathological hallmark of Parkinson’s disease (PD) is the presence of fibrillar aggregates referred to as Lewy bodies (LBs), in which a-synuclein is the major component.. Converging evidence supports the prion-like transmission of a-synuclein aggregates in the onset and progression of PD.. Intracellular asynuclein aggregates into pathological fibrils, which can be transferred from aggregate-producing cells to aggregate-free cells, triggering neuronal injury and the progression of pathology. |
